BamSEC and AlphaSense Join Forces
Learn More

Syros Pharmaceuticals Inc.

NASDAQ: SYRS    
Share price (1/8/25): $0.21    
Market cap (1/8/25): $5.635 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 40 pages Syros Pharmaceuticals, Inc. 4,939,591 Shares of Common Stock, Par Value $0.001 Per Share (The “Common Stock”) Pre-Funded Warrants to Purchase 5,242,588 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.2
from S-3 40 pages Syros Pharmaceuticals, Inc. $50,000,000 Common Stock Sales Agreement
12/34/56
EX-1.1
from 8-K 39 pages Syros Pharmaceuticals, Inc. 5,400,000 Shares of Common Stock, Par Value $0.001 Per Share (The “Common Stock”) Underwriting Agreement
12/34/56
EX-1.2
from S-3 41 pages Syros Pharmaceuticals, Inc. $75,000,000 Common Stock Sales Agreement
12/34/56
EX-1.1
from 8-K 55 pages Loan and Security Agreement
12/34/56
EX-1.2
from 8-K 73 pages Syros Pharmaceuticals, Inc. 666 Shares of Series a Convertible Preferred Stock, Par Value $0.001 Per Share (The “Preferred Stock”) and Class a Warrants to Purchase Up to 166,500 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 58 pages Syros Pharmaceuticals, Inc. 8,667,333 Shares of Common Stock, Par Value $0.001 Per Share (The “Common Stock”) and Class a Warrants to Purchase Up to 1,951,844 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 37 pages Syros Pharmaceuticals, Inc. 4,188,481 Shares of Common Stock, Par Value $0.001 Per Share (The “Common Stock”) Underwriting Agreement
12/34/56
EX-1.2
from S-3 39 pages Syros Pharmaceuticals, Inc. $50,000,000 Common Stock Sales Agreement
12/34/56
EX-1
from SC 13D 1 page Joint Filing Agreement
12/34/56
EX-1.1
from S-1/A 43 pages [Number of Shares] Syros Pharmaceuticals, Inc. Common Stock Underwriting Agreement
12/34/56